AbbVie Inc. (NYSE:ABBV).
Destination Wealth Management bought 7,597 shares last quarter increasing its stake in AbbVie Inc. (ABBV) by 2.2%. Its position was valued at $25,550,000 an increase of 13.7% according to the filing.
Here are a few other firms who have updated their positions. Investec Asset Management Ltd bolstered its investment by buying 43,353 shares an increase of 26.0%. Investec Asset Management Ltd claims 210,331 shares valued at $15,251,000. The value of the position overall is up by 40.2%. As of the end of the quarter Amalgamated Bank had bought a total of 65,579 shares growing its holdings by 53.6%. The value of the investment in AbbVie Inc. went from $7,976,000 to $13,631,000 increasing 70.9% quarter to quarter.
Fort, L.p. grew its ownership by buying 25,275 shares an increase of 25.8% as of 06/30/2017. Fort, L.p. currently owns 123,361 shares worth $8,945,000. The total value of its holdings increased 40.0%.
July 17 investment analysts at Jefferies maintained a company rating of “Buy” and raised the price expectation to $94.00 from $80.00. On July 17 Deutsche Bank left the company rating at “Hold” and moved up the price target from $63.00 to $66.00.
The company is now down by -2.19% since yesterday’s close of $72.02. Additionally the company recently announced a dividend for shareholders that will be paid on Tue Aug 15, 2017. The dividend will be $0.640 per share for the quarter which comes to $2.56 on an annualized basis. This dividend amount will represent a yeild of $3.55. The ex-dividend date will be Wednesday July 12th, 2017.
The stock is trading at $70.44 which is just under the 50 day moving average which is $72.13 and which is well above the 200 day moving average of $66.69. The 50 day moving average moved down $-1.69 and the 200 day average went up $3.75 or +5.62%.
The most current P/E ratio is 17.32 and market cap is 112.29B. As of the last earnings report the EPS was $4.07 and is projected to be $5.52 for the current year with 1,594,094,000 shares presently outstanding. Next quarter’s EPS is forecasted at $1.43 and the next full year EPS is projected to be $6.53.